good points. I personally flip flop on this constantly.my current opinion on this is
CR is a viable option, as a CVN shareholder (and if I cast my mind back to the dim dark uni days) I believe a CR dilutes my personal share of Dorado more than an equity sale does. A CR will be based on previous sp average and generally at a discount. if the CR is only to existing shareholders I'm less concerned about ownership seepage, but the cash requirement is significant so unlikely.
part sale of Dorado. Is effectively a swap of one asset for another. If CVN does a individual farm-out they can hopefully leverage the price set by STOs proposed farm-out. ideally they'd partner with STO so that STO maintains operator ship and CVN would have more negotiation leverage.
ultimately any sale of a part of Dorado will set an evaluation benchmark for CVN which should only benefit shareholders and help stabilise the sp (although I think it will remain volatile until mgmt have proven 100% funding).
- Forums
- ASX - By Stock
- CVN
- Ann: Corporate Presentation - Pavo Discovery
Ann: Corporate Presentation - Pavo Discovery, page-99
-
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CVN (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $290.7M |
Open | High | Low | Value | Volume |
16.5¢ | 16.8¢ | 15.5¢ | $1.388M | 8.584M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 429217 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 518902 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 429217 | 0.160 |
14 | 823700 | 0.155 |
18 | 1275052 | 0.150 |
16 | 738282 | 0.145 |
10 | 342778 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 518902 | 4 |
0.170 | 806729 | 14 |
0.175 | 1047347 | 8 |
0.180 | 470225 | 7 |
0.185 | 269057 | 5 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
CVN (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online